This inventor holds 1 USPTO granted patent. Top assignee: Incyte Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sharada Manns: Inventor in Pharmaceutical Research
Introduction
Sharada Manns is an inventor associated with Wilmington, Delaware, and Incyte Corporation. Her patent work concerns compounds designed to modulate diacylglycerol kinase (DGK), a target relevant to research into diseases including cancer.
Latest Patents
Manns is named on 1 patent: “Tricyclic triazolo compounds as DGK inhibitors.” The application describes tricyclic triazolo compounds that modulate DGK activity and may be useful in treating various diseases, including cancer.
Career Highlights
Manns’s listed invention reflects pharmaceutical research focused on developing compounds that act on a biological target with potential therapeutic applications. The available information identifies her as working at Incyte Corporation.
Collaborations
Joshua Hummel and Liana Hie are identified as Manns’s coworkers. The patent information provided does not specify their individual contributions to the invention.
Conclusion
Sharada Manns’s patent work at Incyte Corporation centers on DGK-modulating compounds and their potential use in disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile